Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Profit After Tax: 2009-2024

Historic Profit After Tax for Tg Therapeutics (TGTX) over the last 16 years, with Dec 2024 value amounting to $23.4 million.

  • Tg Therapeutics' Profit After Tax rose 9974.61% to $390.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $447.5 million, marking a year-over-year increase of 3215.24%. This contributed to the annual value of $23.4 million for FY2024, which is 84.52% up from last year.
  • Latest data reveals that Tg Therapeutics reported Profit After Tax of $23.4 million as of FY2024, which was up 84.52% from $12.7 million recorded in FY2023.
  • In the past 5 years, Tg Therapeutics' Profit After Tax ranged from a high of $23.4 million in FY2024 and a low of -$348.1 million during FY2021.
  • Moreover, its 3-year median value for Profit After Tax was $12.7 million (2023), whereas its average is -$62.6 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first slumped by 61.61% in 2020, then spiked by 105.66% in 2023.
  • Yearly analysis of 5 years shows Tg Therapeutics' Profit After Tax stood at -$279.4 million in 2020, then fell by 24.60% to -$348.1 million in 2021, then surged by 35.70% to -$223.8 million in 2022, then soared by 105.66% to $12.7 million in 2023, then spiked by 84.52% to $23.4 million in 2024.